Akebia Therapeutics, Inc.

SEC 4 · Filed

0001808317-26-000001Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Jun 17, 2026

Grant, award or other acquisition by Wolf Myles

Security
Stock Option (Right to buy)
Code
A
Shares
53,600
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-17",
  "direction": "A",
  "exercise_price": "1.02",
  "expiration": "2036-06-17",
  "footnotes": {
    "F2": "The option to purchase shares of the Issuer\u0027s common stock (the \"Stock Option\") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company\u0027s stockholders occurring after the date of grant), subject to the Reporting Person\u0027s continuous service to the Issuer through such vesting date."
  },
  "owners": [
    {
      "cik": "0001808317",
      "name": "Wolf Myles",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "53600.00",
  "price": "0.00",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Stock Option (Right to buy)",
  "shares": "53600.00",
  "table": "II",
  "underlying_security": "Common Stock",
  "underlying_shares": "53600.00"
}
Insider transactionsEvent date Jun 17, 2026

Grant, award or other acquisition by Wolf Myles

Security
Common Stock
Code
A
Shares
35,700
Price per share
0.00
Structured facts
{
  "code": "A",
  "date": "2026-06-17",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The restricted stock units (the \"RSUs\") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the \"2023 Plan\"), as provided by the Issuer\u0027s Fifth Amended and Restated Non-Employee Director Compensation Program (the \"Program\"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company\u0027s stockholders occurring after the date of grant), subject to the Reporting Person\u0027s continuous service to the Issuer through such vesting date."
  },
  "owners": [
    {
      "cik": "0001808317",
      "name": "Wolf Myles",
      "roles": [
        "director"
      ],
      "title": null
    }
  ],
  "ownership": "D",
  "post_shares": "169081.00",
  "price": "0.00",
  "row": 1,
  "rule_10b5_1": "false",
  "security": "Common Stock",
  "shares": "35700.00",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}